Up next

Autoplay

Advances in understanding the molecular pathogenesis of CTCL

4 Views • 08/09/23
Share
Embed
administrator
administrator
Subscribers
0

Rudolf Stadler, MD, PhD, University Medical Center Minden, Minden, Germany, discusses recent advances in our understanding of the molecular pathogenesis of cutaneous T-cell lymphoma (CTCL), highlighting the role of PD-1, and commenting on how these developments may advance therapeutic approaches. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay